CYP1A1 polymorphisms and risk of lung cancer in the ethnic Kashmiri population

Asian Pacific Journal of Cancer Prevention

Volumn 10, Issue 4, 2009, Pages 651-656

  Sheikh, Shaffi M ^a   Amin Shah, Mohd ^a   Ahmad Bhat, Imtiyaz ^a   Koul, Parvaiz ^a   Nisar Ahmad, Syed ^b   Siddiqi, Mushtaq A ^a  

^a Department of Immunology and Molecular Medicine ^*  (India)

^b SHER I KASHMIR INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

CYP1A1 polymorphisms; Histology; Lung cancer; Tobacco smoking

Indexed keywords

EID: 77951108720     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Alexandrie AK, Sundberg MI, Siedegard J, et al (1994). Genetic susceptibility to lung cancer with special emphasis to CYP1A1 and GSTM1: a study on host factors in relation to age at onset, gender and histological cancer types. Carcinogenesis, 15, 1785-90
2. Bartsch H, Nair U, Risch A, et al (2000). Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. Cancer Epidemiol Biomarkers Prev, 9, 3-28
3. Bouchardy C, Wikman H, Benhamou S, et al (1997) CYP1A1 genetic polymorphism, tobacco smoking and lung cancer risk in a French Caucasian population. Biomarkers, 2, 131-4
4. Crofts F, Taioli E, Trachman J, et al (1994). Functional significance of different human CYP1A1 genotypes. Carcinogenesis, 15, 2961-3
5. Crofts F, Cosma GN, Currie D, et al (1993). A novel CYP1A1 gene polymorphism in African-Americans. Carcinogenesis, 14, 1729-31
6. Cosma G, Crofts F, Taioli E, et al (1993). The relationship between genotype and function of the human CYP1A1 gene. J Toxicol Environ Health, 40, 309-16
7. Cosma GN, Crofts F, Currie D, et al (1993). Racial differences in restriction fragment length polymorphism and mRNA inducibility in human CYP1A1 gene. Cancer Epidemiol Biomarker Prev, 2, 53-7
8. Cascorbi I, Brockmoller J, Roots I (1996). A C4887A poly-morphism in exon 7 of human CYP1A1: population frequency, mutation linkages and impact on lung cancer susceptibility. Cancer Res, 56, 4965-9
9. Carlsten C, Sagoo GS, Frodsham AJ, et al (2008). Glutathione S-transferase M1 (GSTM1) polymorphisms and lung cancer: a literature-based systematic HuGE review and metaanalysis. Am J Epidemiol, 167, 759-74
10. Deutsch-Wenzel RvH, Grimmer G, Dettbarn G, Misfeld J (1983). Experimental studies in rat lungs on the carcinogenicity and dose response relationship of eight frequently occurring environemtal polycliniclal aromatic hydrocarbons. J Natl Cancer Inst, 71, 539-44
11. Greenblatt MS, Bennett WP, Hollstein M, Harris CC (1994). Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res, 54, 4855-78
12. Garte S (1998). The role of ethnicity in cancer susceptibility gene polymorphisms: the example of CYP1A1. Carcinogenesis, 19, 1329-32
13. Gonzalez FP (1997). The role of carcinogen-metabolizing enzyme polymorphisms in cancer susceptibility. Reprod Toxicol, 11, 397-412
14. Gonzalez FJ, Gelboin HV (1994). Role of human cytochromes P450 in the metabolic activation of chemical carcinogens and toxins. Drug Metab Rev, 26, 165-83
15. Hukkanen J, Pelkonen O, Hakkola J, Raunio H (2002). Expression and regulation of xenobiotic-metabolizing cytochrome P450 (CYP) enzymes in human lung. Crit Rev Toxicol, 32, 391-411
16. Hayashi S, Watanabe J, Kawajiri K (1992). High susceptibility to lung cancer analyzed in terms of combined genotypes of CYP1A1 and Mu class glutathione-S-transferase genes. Jpn J Cancer Res, 83, 866-70
17. Hong YS, Chang JH, Kwon OJ, Ham YA, Choi JH (1998). Polymorphism of the CYP1A1 and glutathione-S-transferase genes in Korean lung cancer patients. Exp Mol Med, 30, 192-8
18. Hirvonen A, Putsianen KH, Karjalainen A, Antilla S, Vainio H (1992). Point mutational MspI and Ile/Val polymorphism closely linked in the CYP1A1 gene; lack of association with susceptibility to lung cancer in a Finnish study population. Cancer Epidemiol Biomarkers Prev, 1, 485-9
19. Kiyohara C, Hirohata T, Inutsuka S (1996). The relationship between aryl hydrocarbon hydroxylase and polymorphisms of the CYP1A1 gene. Jpn J Cancer Res, 87, 18-24
20. Kiyohara C, Nakanishi Y, Inutsuka S, et al (1998). The relationship between CYP1A1 and aryl hydrocarbon hydroxylase activity and lung cancer in a Japanese population. Pharmacogenetics, 8, 315-23
21. Landi MT, Bertazzi PA, Shields PG, et al (1994). Association between CYP1A1 genotype, mRNA expression and enzymatic activity in humans. Pharmacogenetics, 4, 242-6
22. Lin P, Wang SL, Wang JH, et al (2000). Association of CYP1A1 and microsomal epoxide hydrolase polymorphisms with lung squamous cell carcinoma. Br J Cancer, 82, 852-7
23. Marchand Le, Sivaraman L, Pierce L, et al (1998). Association of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens. Cancer Res, 58, 4858-63
24. Munish K, Sudhir K, Agarwal S, Goel K (2009). Lung cancer risk in north Indian population: role of genetic polymorphisms and smoking. Mol Cell Biochem, 322, 73-9
25. Nebert DW, Mckinnon RA, Puga A (1996). Human drug metabolizing enzyme polymorphisms: effects on risk of toxicity and cancer. DNA Cell Biol, 15, 273-80
26. Nakachi K, Imai K, Hayashi S, Watanabe J, Kawajiri K (1991). Genetic susceptibility to squamous cell carcinoma of the lung in relation to tobacco smoking dose. Cancer Res, 51, 5177-80
27. Nakachi K, Imai K, Hayashi S, Kawajiri K (1993) Polymorphisms of the CYP1A1 and glutathione S transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. Cancer Res, 53, 2994-9
28. Shah PP, Singh AP, Singh M, et al (2008). Interaction of cytochrome P4501A1 genotypes with other risk factors and susceptibility to lung cancer. Mutat Res, 639, 1-10
29. Petersen DD, McKinney CE, Iyeka K, et al (1991). Human CYP1A1 gene: Co-segregation of the enzymeinducibility phenotype and an RFLP. Am J Hum Genet, 48, 720-5
30. Sugimura H, Wakai K, Genka K, et al (1998). Association of Ile462Val (exon 7) polymorphism of cytochrome P450 IA1 with lung cancer in the Asian population: further evidence froma case-control study in Okinawa. Cancer Epidemiol Biomark Prev, 7, 413-7
31. Song N, Tan W, Xing D, Lin D (2001). CYP 1A1 polymorphism and risk of lung cancer in relation to tobacco smoking: a case-control study in China. Carcinogenesis, 22, 11-6
32. Sobti RC, Sharma S, Joshi A, Jindal SK, Janmeja A (2003). CYP1A1 and CYP2D6 polymorphism and risk of lung cancer in a North Indian population. Biomarkers, 8, 415-28
33. Sobti RC, Sharma S, Joshi A, Jindal SK, Janmeja A (2004) Genetic polymorphism of the CYP1A1, CYP2E1, GSTM1 and GSTT1 genes and lung cancer susceptibility in a North Indian population. Mol Cell Biochem, 266, 1-9
34. Sreeja L, Syamala V, Hariharan S, et al (2005) Possible risk modification by CYP1A1, GSTM1 and GSTT1 gene polymorphisms in lung cancer susceptibility in a South Indian population, J Hum Genet, 50, 618-27
35. Spivack SD, Hurteau GJ, Reilly AA, et al (2001). CYP1B1 expression in human lung. Drug Metab Dispos, 29, 916-22
36. Song N, Tan W, Xing D, Lin D (2001). CYP1A1 polymorphism and risk of lung cancer in relation to tobacco smoking: a case-control study in China. Carcinogenesis, 22, 11-6
37. Shields PG, Caporaso NE, Falk RI, et al (1993). Lung cancer, race and a CYP1A1 genetic polymorphism. Cancer Epidemiol Biomarker Prev, 2, 581-5
38. Takeshima Y, Seyama, Bennett WP, et al (1993). p53 mutations in lung cancer from non-smoking atomic bomb survivors. Lancet, 342, 150-21
39. Wu X, Shi H, Jiang H, Kemp B, et al (1997). Association between cytochrome p4502E1 genotype, mutagen sensitivity, cigarette smoking and susceptibility to lung cancer. Carcinogenesis, 18, 967-73